The Development of Inhibitors of Heparanase, a Key Enzyme Involved in Tumour Metastasis, Angiogenesis and Inflammation

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 6, 2004-01 ,pp. : 693-702

Bentham Science Publishers

Access to resources Recommend Favorite

CYP4 Enzymes As Potential Drug Targets: Focus on Enzyme Multiplicity, Inducers and Inhibitors, and Therapeutic Modulation of 20- Hydroxyeicosatetraenoic Acid (20-HETE) Synthase and Fatty Acid ω- Hydroxylase Activities

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 12, 2013-06 ,pp. : 1429-1440

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Click-Chemistry in the Development of Peptidomimetic Enzyme Inhibitors

By  

Current Medicinal Chemistry, Vol. 21, Iss. 13, 2014-04 ,pp. : 1467-1477

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Development of Endocannabinoid-Hydrolyzing Enzyme Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 8, 2010-06 ,pp. : 828-858

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of CYP2C19 inhibitors from phytochemicals using the recombinant human enzyme model

By Kong L.M.   Xu S.Y.   Hu H.H.   Zhou H.   Jiang H.D.   Yu L.S.   Zeng S.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 5, 2014-05 ,pp. : 362-366

Govi-Verlag

Access to resources Recommend Favorite